5.37
Optinose Inc 주식(OPTN)의 최신 뉴스
Optinose to Announce Q4 and Full-Year 2024 Financial Results on March 20, 2025 - MyChesCo
OptiNose (NASDAQ:OPTN) shareholders have endured a 90% loss from investing in the stock five years ago - Yahoo Finance
OptiNose (OPTN) Projected to Post Quarterly Earnings on Thursday - Defense World
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Optinose to Announce Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 - Nasdaq
Optinose to Reveal Full Year Performance: Key Financial Results Coming March 20 - StockTitan
OptiNose, Inc. to Host Earnings Call - ACCESS Newswire
How the (OPTN) price action is used to our Advantage - Stock Traders Daily
Optinose CEO Mahmoud Ramy sells $33,729 in common stock By Investing.com - Investing.com South Africa
Optinose chief commercial officer sells $6,469 in stock - Investing.com India
Optinose chief commercial officer sells $6,469 in stock By Investing.com - Investing.com South Africa
Optinose CEO Mahmoud Ramy sells $33,729 in common stock - Investing.com
OptiNose Executives Sell Shares to Cover Tax Obligations - TradingView
Long Term Trading Analysis for (OPTN) - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Growth in Short Interest - MarketBeat
(OPTN) Technical Pivots with Risk Controls - Stock Traders Daily
OptiNose, Inc. (NASDAQ:OPTN) Sees Significant Decline in Short Interest - MarketBeat
Optinose Reports $22.4 Million in Preliminary Q4 Revenue for XHANCE - MSN
OptiNose (STU:0OP0) Inventories, Raw Materials & Components : €2.05 Mil (As of Sep. 2024) - GuruFocus.com
OptiNose (FRA:0OP0) Earnings per Share (Diluted) : €-3.84 (TTM As of Sep. 2024) - GuruFocus.com
Lake Street Capital Issues Pessimistic Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
OptiNose (NASDAQ:OPTN) Price Target Cut to $17.00 by Analysts at Lake Street Capital - MarketBeat
OptiNose (FRA:0OP0) Short-Term Capital Lease Obligation : €0.91 Mil (As of Sep. 2024) - GuruFocus.com
Optinose price target adjusted for stock split at Lake Street - Yahoo Finance
Optinose reports preliminary Q4 2024 XHANCE revenue - MSN
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewswire
OPTNOptiNose, Inc. Latest Stock News & Market Updates - StockTitan
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Optinose Reports Strong Q4: XHANCE Revenue Hits $22.4M with 20% Prescription Growth - StockTitan
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors - GlobeNewswire Inc.
OptiNose (STU:0OP0) Profitability Rank : 3 (As of Sep. 2024) - GuruFocus.com
OptiNose (STU:0OP0) Change In Inventory : €-3.06 Mil (TTM As of Sep. 2024) - GuruFocus.com
OptiNose, Inc. (NASDAQ:OPTN) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
OptiNose (FRA:0OP0) Cyclically Adjusted Price-to-FCF : (As of Jan. 06, 2025) - GuruFocus.com
HC Wainwright Comments on OptiNose FY2029 Earnings - MarketBeat
HC Wainwright Forecasts OptiNose FY2029 Earnings - Defense World
Optinose price target adjusted for stock split at H.C. Wainwright - MSN
HC Wainwright Issues Positive Forecast for OptiNose (NASDAQ:OPTN) Stock Price - Defense World
Optinose stock price target raised at H.C. Wainwright given reverse split - Investing.com Canada
OptiNose (NASDAQ:OPTN) Shares Down 6.1%Time to Sell? - MarketBeat
OptiNose: Q1 Earnings Snapshot - Marketscreener.com
OptiNose, Inc. Announces Executive Appointments - Marketscreener.com
Optinose Announces Board Changes - Marketscreener.com
OptiNose stock hits 52-week high of $6.2 amid market fluctuations - Investing.com Nigeria
OptiNose stock hits 52-week high of $6.2 amid market fluctuations By Investing.com - Investing.com South Africa
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
OptiNose (NASDAQ:OPTN) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
자본화:
|
볼륨(24시간):